Prognostic significance of the Fas-receptor/Fas-ligand system in cervical squamous cell carcinoma
✍ Scribed by Enrique Lerma; Marisa Romero; Alberto Gallardo; Cristina Pons; Josefina Muñoz; Josefina Fuentes; Belen Lloveras; Lluis Catasus; Jaime Prat
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 334 KB
- Volume
- 452
- Category
- Article
- ISSN
- 1432-2307
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background and Objectives: Fas (APO-1) induces apoptosis after binding Fas ligand (FasL). Evidence suggests that tumors may use this interaction to evade the host immune response. Fas/FasL expression has not been reported in esophageal cancer. We hypothesized that Fas expression would render esophag
CD95 (Apo-1/Fas) ligand (CD95L) expression has been observed in various malignancies. In human primary cell lines from a squamous cell carcinoma (SCC) of the vulva, the effect of cisplatin (CDDP) and IFN␥ on the expression of CD95L and its 2 receptor isoforms, CD95 transmembrane (CD95tm) and CD95 so
## BACKGROUND. Esophageal carcinoma is one of the most lethal tumors. Therefore, it is important to identify prognostic factors for patients with this disease. The objective of this study was to clarify the relation between clinicopathologic and biologic factors in esophageal carcinoma and to dete